Skip to main content
Equibles
DMRA logo

DMRA · Damora Therapeutics, Inc. · Exempt Offerings

Track DMRA — free

Use DMRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DMRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.10 +1.26 (+4.69%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$1.73B
Shares
61.74M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2025-11-21 New $285,000,000 $285,000,000
2020-11-05 New $64,199,679 $64,199,679
2020-01-16 New $123,718,248 $79,143,223
Showing 1–3 of 3 filings
Key facts CIK 1800315 CUSIP G2646Y104 13F (30d) 52 filings 52 filers Visit website Investor relations